This week, included are two reports of safety issues (Depo Provera and Ozempic) that did not involve an FDA update but are noteworthy due to lawsuits and European Medicines Agency (EMA) interest.
Share this post
January 2025 Part 1: Safety warning for RSV…
Share this post
This week, included are two reports of safety issues (Depo Provera and Ozempic) that did not involve an FDA update but are noteworthy due to lawsuits and European Medicines Agency (EMA) interest.